Gene · 9134
CCNE2: cyclin E2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCNE2: cyclin E2. Genes, record 9134. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9134
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O96020 | G1/S-specific cyclin-E2 | 404 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents68
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 4166 | O96020 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4843 | O96020 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4166 | O96020 | Espacenet |
| JP 2025024198 A | 2025-02-19 | 11500 | O96020 | Espacenet |
| JP 2025024198 A | 2025-02-19 | 11502 | O96020 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4843 | O96020 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 128 | O96020 | Espacenet |
| US 11708396 B2 | 2023-07-25 | 2190 | O96020 | Espacenet |
| US 11708396 B2 | 2023-07-25 | 2194 | O96020 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 21060 | O96020 | Espacenet |
1 to 10 of 68
See all 68 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,511
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCNE2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 31 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 10 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 7 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 7 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 6 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 5 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 5 | 2025 |
| P01AI127335 | Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation | 4 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,511Source NIH's project files
See all 1,511 nih grantsPapers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT. | Adv Sci (Weinh) | 2026 | 42658569 | PubTator, text mining | PubMed |
| Feed restriction affects follicular development by regulating cell cycle progression in porcine mural granulosa cells. | J Anim Sci Biotechnol | 2026 | 42482127 | PubTator, text mining | PubMed |
| Self-organizing three-dimensional dermal papilla cell spheroids yield therapeutic extracellular vesicles that target hypertrophic scar regression via the miR-26a-5p/CCNE2 axis. | Burns Trauma | 2026 | 42421776 | PubTator, text mining | PubMed |
| Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells. | Food Chem Toxicol | 2026 | 42303079 | PubTator, text mining | PubMed |
| [MUTYH-APEX1 Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | 42021884 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition. | Cell Death Dis | 2026 | 41888518 | PubTator, text mining | PubMed |
| Precision Design in Cancer Treatment: Cucurbitacin E Modulates AMPK, PGK1, and PKM2 to Optimize Radiation Efficacy in Melanoma. | Curr Pharm Des | 2026 | 41832669 | PubTator, text mining | PubMed |
| Hsa-microRNA-34a-5p inhibits virus-negative Merkel cell carcinoma cell proliferation and migration by regulating cell cycle- and EMT-related pathways and suppresses tumor spheroid formation. | J Dermatol Sci | 2026 | 41820098 | PubTator, text mining | PubMed |
| Understanding the Mechanisms of Human Liver Regeneration via Characterization of Circulating Extracellular Vesicles. | Biomed Res Int | 2026 | 41810218 | PubTator, text mining | PubMed |
| PVT1 lincRNA signals an androgen-dependent transcriptional activation program of oncogenes in prostate cancer cells. | Int J Cancer | 2026 | 41792045 | PubTator, text mining | PubMed |
1 to 10 of 2,792
See all 2,792 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9134
GET https://conductscience.org/api/genes/v1/9134/patents?page=2